Alniche Life Sciences Pvt. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Alniche Life Sciences Pvt. Ltd. - overview
Established
2007
Location
New Delhi, -, India
Primary Industry
Pharmaceuticals
About
Alniche Life Sciences Pvt. Ltd. is an Indian company focused on developing and commercializing innovative healthcare products, providing affordable medicines and wellness solutions across various therapeutic areas. Alniche Life Sciences Pvt.
Ltd. was founded in 2007 in New Delhi, India, specializing in healthcare solutions. The company was acquired by InvAscent Capital Partners in July 2018 for INR 680 million. The CEO, Jayan Menon, brings substantial experience to the firm, although details of previous ventures are not specified.
Alniche Life Sciences Pvt. Ltd. specializes in the development and commercialization of innovative healthcare products, focusing on high-quality, affordable medicines and wellness solutions. The company's core product offerings encompass a diverse portfolio across various therapeutic areas, including renal care, life care, dermatological products, gastroenterology, and neuropsychiatry.
These products are designed to address unmet medical needs, improve patient outcomes, and enhance overall quality of life. Alniche's clientele includes healthcare providers, hospitals, and global healthcare organizations, with products distributed primarily within India and targeted expansions into North America and Africa. The company's commitment to effective solutions is evident in its strategic focus on deep engagement with the medical community, facilitating tailored products that meet the specific needs of end-users. In the most recent year, 2023, Alniche Life Sciences reported revenue of INR 35,971,131.
70 and an EBITDA of INR 1,579,751. 10. The company generates revenue through a combination of direct sales and partnerships with global healthcare organizations, ensuring efficient delivery of their specialty products. Alniche Life Sciences plans to expand its product offerings with new healthcare solutions targeting unmet medical needs in the coming years.
The company is focusing on entering new markets, specifically North America and Africa, with a timeline yet to be established. The recent funding of INR 680 million from InvAscent Capital Partners will support these expansion initiatives and product development efforts.
Current Investors
InvAscent Capital Partners
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.alniche.com
Verticals
Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Alniche Life Sciences Pvt. Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Alniche Life Sciences Pvt. Ltd. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.